Biomedical Research

Documents

FDA

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDAOpen for comment

Citizen Petition from Regina Sutton

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Acknowledgement Letter from FDA DMB to Regina Sutton

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 1 - Gadolinium-Based Contrast Media Nephrotoxicity in Kidney Impairment

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 2 - Gadolinium-based MRI contrast agent effects on calcium signaling

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 3 - Gadolinium retention effect on macrophages

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 4 - Gadolinium accelerates the migration of astrocyte via integrin signaling pathway

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 5 - Concentration-Dependent Bidirectional Modification of Evoked Synaptic Transmission by Gadolinium

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 6 - Literature case analysis of nephrogenic systemic fibrosis induced by gadolinium-based contrast agents

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 7 - Incorporation of excess gadolinium into human bone from medical contrast agents

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 8 - Repeated gadolinium

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →
FDA

Reference 9 - Gadolinium Mitochondrial Toxicity

0 comments

Analysis in progress

Top issues in comments

Not yet determined
Read the record →